Phase 2 data for from the Believe-PV study for PRN1008 show that the investigational agent from Principia Biopharma reached the primary efficacy measure in pemphigus. Data confirm that Sebacia microparticles confer benefit in the management of acne vulgaris in real-world settings. Candela has rebranded to reflect the unification of the Syneron and Candela brands. Dupixent from Regeneron Pharmaceuticals and Sanofi is now approved to treat atopic dermatitis in patients ages 12 through 17.
News | April 8, 2019
To recognize their dedication in helping people with psoriasis and psoriatic arthritis as volunteers, members, and donors, the National Psoriasis Foundation (NPF) elected Jerry Bagel MD, MS of East Windsor, NJ, Mike Refermat of San Diego,...
News | April 19, 2019
Fibrocell Science, Inc. has entered into a collaboration agreement with Castle Creek Pharmaceuticals to develop and commercialize Fibrocell’s lead gene therapy candidate, FCX-007, for the treatment of recessive dystrophic...
News | March 28, 2019
BTL is rolling out a small Emsculpt applicator to treat arms, thighs and calves at the annual meeting of the American Society for Laser Medicine and Surgery in Denver. Until now, there were only protocols for the abdominals and...
Acquisitions and Mergers
Business of Medicine
Earnings and Financials
Phase 3/4 Trials
Product Launches and Updates
Research and Publications
Skin of Color
Fibrocell to Collaborate with Castle Creek Pharmaceuticals to Develop and Commercialize RDEB Gene Therapy
La Roche-Posay to Sponsor a Patient to Visit Thermal Dermatology Center: Accepting Nominations
Allergan 360° Aesthetics Report Shines Light on Evolving Beauty Perceptions Around the World
PALLAS Ti: Sapphire Solid State Laser Shows Similar Efficacy and Safety to 308nm Excimer Laser for Localized Vitiligo